Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
0.982
+0.002 (0.17%)
Nov 21, 2024, 11:27 AM EST - Market open
Opus Genetics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 31 | 68 | 73 | 65 | 70 | - | |
| Market Cap Growth | -51.23% | -7.23% | 13.82% | -8.29% | - | - | |
| Enterprise Value | -6 | 26 | 59 | 42 | 79 | - | |
| Last Close Price | 0.98 | 3.01 | 3.53 | 3.73 | 6.49 | - | |
| Forward PE | - | - | 14.07 | - | - | - | |
| Debt / Equity Ratio | - | - | - | 0.02 | - | -0.75 | |
| Asset Turnover | 0.18 | 0.37 | 1.06 | 0.03 | - | - | |
| Quick Ratio | 6.56 | 13.07 | 17.27 | 6.42 | 5.15 | 0.16 | |
| Current Ratio | 6.63 | 13.35 | 17.79 | 6.76 | 5.55 | 0.19 | |
| Return on Equity (ROE) | -64.30% | -20.77% | 52.26% | -1295.10% | - | - | |
| Return on Assets (ROA) | -38.95% | -12.83% | 30.35% | -64.86% | -60.79% | -226.20% | |
| Return on Capital (ROIC) | -43.56% | -13.73% | 33.02% | -305.40% | - | - | |
| Buyback Yield / Dilution | -13.36% | -4.82% | -38.68% | -218.65% | -63.84% | -19.08% | |
| Total Shareholder Return | -13.36% | -4.82% | -38.68% | -218.65% | -63.84% | -19.08% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.